Income Statement ICON Public Limited Company
Equities
ICLR
IE0005711209
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.02 USD | +2.89% |
|
+2.12% | -23.22% |
| 11-13 | BMO Capital Initiates Coverage on ICON With Market Perform Rating, $175 Price Target | MT |
| 10-24 | Truist Trims Price Target on ICON PLC to $231 From $234, Keeps Buy Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.8B | 5.48B | 7.74B | 8.12B | 8.28B | |||||
Total Revenues | 2.8B | 5.48B | 7.74B | 8.12B | 8.28B | |||||
Cost of Goods Sold, Total | 1.98B | 3.97B | 5.52B | 5.71B | 5.84B | |||||
Gross Profit | 820M | 1.51B | 2.22B | 2.41B | 2.44B | |||||
Selling General & Admin Expenses, Total | 344M | 588M | 783M | 776M | 736M | |||||
Stock-Based Compensation (IS) | - | 73.84M | - | - | - | |||||
Depreciation & Amortization - (IS) | 66.13M | 315M | 570M | 586M | 488M | |||||
Other Operating Expenses, Total | 410M | 977M | 1.35B | 1.36B | 1.22B | |||||
Operating Income | 410M | 534M | 866M | 1.05B | 1.22B | |||||
Interest Expense, Total | -13.02M | -182M | -230M | -337M | -237M | |||||
Interest And Investment Income | 2.72M | 574K | 2.34M | 5.01M | 8.61M | |||||
Net Interest Expenses | -10.3M | -182M | -227M | -332M | -229M | |||||
Income (Loss) On Equity Invest. | -366K | -2.16M | -3.14M | -383K | - | |||||
EBT, Excl. Unusual Items | 399M | 350M | 636M | 714M | 991M | |||||
Restructuring Charges | -18.09M | -31.1M | -31.14M | -45.39M | -92.12M | |||||
Merger & Related Restructuring Charges | - | -124M | -39.7M | -44.18M | -29.57M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 381M | 195M | 565M | 624M | 869M | |||||
Income Tax Expense | 47.88M | 41.33M | 59.41M | 11.75M | 77.71M | |||||
Earnings From Continuing Operations | 333M | 153M | 505M | 612M | 791M | |||||
Net Income to Company | 333M | 153M | 505M | 612M | 791M | |||||
Minority Interest | -633K | - | - | - | - | |||||
Net Income - (IS) | 332M | 153M | 505M | 612M | 791M | |||||
Preferred Dividend and Other Adjustments | 4.52M | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 328M | 153M | 505M | 612M | 791M | |||||
Net Income to Common Excl. Extra Items | 328M | 153M | 505M | 612M | 791M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.2 | 2.28 | 6.2 | 7.46 | 9.6 | |||||
Basic EPS - Continuing Operations | 6.2 | 2.28 | 6.2 | 7.46 | 9.6 | |||||
Basic Weighted Average Shares Outstanding | 52.86M | 67.11M | 81.53M | 82.1M | 82.48M | |||||
Net EPS - Diluted | 6.15 | 2.25 | 6.13 | 7.4 | 9.53 | |||||
Diluted EPS - Continuing Operations | 6.15 | 2.25 | 6.13 | 7.4 | 9.53 | |||||
Diluted Weighted Average Shares Outstanding | 53.28M | 68.07M | 82.47M | 82.72M | 83.03M | |||||
Normalized Basic EPS | 4.7 | 3.26 | 4.87 | 5.43 | 7.51 | |||||
Normalized Diluted EPS | 4.67 | 3.21 | 4.82 | 5.39 | 7.46 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 476M | 849M | 1.44B | 1.63B | 1.71B | |||||
EBITA | 429M | 774M | 1.33B | 1.51B | 1.57B | |||||
EBIT | 410M | 534M | 866M | 1.05B | 1.22B | |||||
EBITDAR | 506M | 899M | 1.49B | 1.68B | 1.75B | |||||
Total Revenues (As Reported) | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 12.57 | 21.25 | 10.52 | 1.88 | 8.94 | |||||
Current Domestic Taxes | 28.96M | 18.47M | 53.25M | 80.43M | 118M | |||||
Current Foreign Taxes | 17.98M | 83.48M | 131M | 16.72M | 60M | |||||
Total Current Taxes | 46.95M | 102M | 184M | 97.15M | 178M | |||||
Deferred Domestic Taxes | 1.65M | 553K | -6.17M | 45.25M | -26.66M | |||||
Deferred Foreign Taxes | -727K | -61.17M | -119M | -131M | -73.88M | |||||
Total Deferred Taxes | 927K | -60.62M | -125M | -85.4M | -101M | |||||
Normalized Net Income | 249M | 219M | 397M | 446M | 619M | |||||
Interest on Long-Term Debt | - | - | - | 337M | 237M | |||||
Non-Cash Pension Expense | -326K | 119K | -358K | -314K | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 7.02M | - | - | - | - | |||||
Selling and Marketing Expenses | 7.02M | - | - | - | - | |||||
Net Rental Expense, Total | 30.15M | 49.9M | 52.72M | 45.72M | 44.9M | |||||
Imputed Operating Lease Interest Expense | 7.07M | 23.96M | 18.5M | 28.09M | 22.6M | |||||
Imputed Operating Lease Depreciation | 23.08M | 25.94M | 34.22M | 17.63M | 22.3M | |||||
Stock-Based Comp., COGS (Total) | 8.56M | 18.55M | 22.85M | 26.6M | 26.05M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 17.71M | 41.46M | 47.67M | 29.07M | 19.82M | |||||
Stock-Based Comp., Other (Total) | - | 73.84M | - | - | - | |||||
Total Stock-Based Compensation | 26.27M | 134M | 70.52M | 55.67M | 45.87M |
- Stock Market
- Equities
- ICLR Stock
- Financials ICON Public Limited Company
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















